Eli Lilly (LLY) Change in Acquisitions & Divestments (2009 - 2025)

Eli Lilly (LLY) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $132.0 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 135.71% year-over-year to $132.0 million; the trailing twelve-month figure through Dec 2025 stood at $964.0 million (up 157.75% YoY), and the FY2025 full-year result was $964.0 million, up 157.75% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at $132.0 million, down from $556.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $753.4 million in Q4 2021 and bottomed at -$172.3 million in Q2 2023.
• The 5-year median for Change in Acquisitions & Divestments is $69.2 million (2024), against an average of $149.4 million.
• The widest annual swing landed in 2021, when Change in Acquisitions & Divestments jumped 6811.93%; it then plunged 657.61% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $753.4 million in 2021, then tumbled by 65.61% to $259.1 million in 2022, then surged by 36.16% to $352.8 million in 2023, then sank by 84.13% to $56.0 million in 2024, then soared by 135.71% to $132.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $132.0 million (Q4 2025), $556.1 million (Q3 2025), and $204.3 million (Q2 2025), per Business Quant data.

Peer Comparison